Paul Singer’s Elliott Investment Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund exited two positions ...

Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...

Gilgal Medical Supplies recently transitioned to a retail sales and wholesale distribution model for medical supplies, a decision made necessary by the increasing burdens associated with ...

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”) collaborations aligned with Orchestra BioMed’s partnership-enabled ...

The biopsy devices market is expanding rapidly, driven by rising cancer cases, technological advancements, and minimally invasive procedures. Demand for precision diagnostics fuels innovation.” - ...

Draped in Mexican and Salvadoran flags, roughly 1,000 demonstrators gathered near City Hall shortly before noon, blocking ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The Allstate Corporation has reached a definitive agreement to sell its group health business to Nationwide for $1.25 billion in cash, subject to adjustments based on the closing balance sheet and ...

US primary insurer, The Allstate Corporation, has entered into a definitive agreement to sell its Group Health business to Nationwide for $1.25 billion in cash, adjusted for the closing balance sheet, ...